France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

Explore QuantumScape's Q1 2025 earnings call insights, featuring progress on solid-state battery tech, Cobra process milestones, and partnerships ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...